Table 3

Secondary outcome measures

Ultrasound tailored treatmentUsual careBetween-group difference
 Mean95% CIp Value
Outcome variableNMean (SD)NMean (SD)difference*LowerUpper
SPS
 Baseline5620.6 (4.1)5519.5 (4.3)
 3 months5314.3 (5.1)5315.2 (5.5)−2.1−4.20.10.06
 6 months4713.1 (4.7)4713.5 (5.4)−1.7−3.80.50.13
 12 months5111.1 (5.3)5011.5 (4.8)−1.7−3.90.50.12
SDQ
 Baseline5669.6 (17.3)5568.3 (17.2)
 3 months5347.2 (32.4)5349.4 (29.8)−4.3−14.96.30.42
 6 months4740.7 (29.7)4736.3 (27.1)3.2−8.114.40.58
 12 months5124.3 (30.2)5031.0 (29.7)−6.9−19.96.10.29
EQ-5D
 Baseline560.68 (0.20)550.73 (0.22)
 3 months530.76 (0.21)530.79 (0.22)0.01−0.070.090.74
 6 months470.83 (0.18)470.84 (0.18)0.05−0.040.130.26
 12 months510.81 (0.27)500.87 (0.16)0.002−0.100.100.97
EQ-5D VAS
 Baseline5669.4 (15.2)5569.9 (14.2)
 3 months5372.6 (17.6)5373.1 (13.7)0.13−5.164.900.96
 6 months4778.4 (12.0)4776.5 (13.7)2.82−2.648.290.31
 12 months5178.3 (15.8)5077.4 (14.5)1.62−4.768.000.62
  • *Linear mixed model analysis corrected for baseline and age (stratification variable, cut-off 50 years) and variation at the level of the GP practice, patient and repeated observations. The level-3 variance (GP practice) was equal to 0 for SPS and EQ-5D. The interaction between group and time was not significant.

  • EQ-5D VAS, Visual Analogue Scale 0–100 (100=best health status); EQ-5D, Euroqol five-item quality of life questionnaire tariff −1 to 1 (1=highest health-related quality of life); SDQ, Shoulder Disability Questionnaire 0–100 (100=most severe disability); SPS, Shoulder Pain Score 7–28 (28=most pain).